Nuveen Asset Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-410,636
| Closed | -$965K | – | 3329 |
|
|
2024
Q1 | $965K | Buy |
410,636
+216,832
| +112% | +$510K | ﹤0.01% | 2722 |
|
|
2023
Q4 | $366K | Buy |
193,804
+31,012
| +19% | +$58.6K | ﹤0.01% | 3103 |
|
|
2023
Q3 | $223K | Sell |
162,792
-964
| -0.6% | -$1.32K | ﹤0.01% | 3021 |
|
|
2023
Q2 | $398K | Buy |
163,756
+69,071
| +73% | +$168K | ﹤0.01% | 2957 |
|
|
2023
Q1 | $545K | Sell |
94,685
-5,326
| -5% | -$30.7K | ﹤0.01% | 2789 |
|
|
2022
Q4 | $894K | Sell |
100,011
-12,842
| -11% | -$115K | ﹤0.01% | 2724 |
|
|
2022
Q3 | $1.61M | Buy |
112,853
+6,984
| +7% | +$99.3K | ﹤0.01% | 2518 |
|
|
2022
Q2 | $1.55M | Buy |
105,869
+24,272
| +30% | +$354K | ﹤0.01% | 2573 |
|
|
2022
Q1 | $1.23M | Buy |
81,597
+28,780
| +54% | +$435K | ﹤0.01% | 2726 |
|
|
2021
Q4 | $750K | Sell |
52,817
-12,909
| -20% | -$183K | ﹤0.01% | 2951 |
|
|
2021
Q3 | $473K | Buy |
65,726
+3,629
| +6% | +$26.1K | ﹤0.01% | 3176 |
|
|
2021
Q2 | $639K | Buy |
+62,097
| New | +$639K | ﹤0.01% | 3129 |
|
|
2019
Q4 | – | Sell |
-5,728
| Closed | -$354K | – | 3170 |
|
|
2019
Q3 | $354K | Hold |
5,728
| – | – | ﹤0.01% | 3024 |
|
|
2019
Q2 | $409K | Buy |
+5,728
| New | +$409K | ﹤0.01% | 3053 |
|